Clinical Trials
30 trialsNCT06995833 2026-05-13
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
AstraZeneca
Recruiting
NCT06890273 2026-05-12
DUOLife
AstraZeneca
Recruiting
NCT07124000 2026-05-01
DP-04
AstraZeneca
Recruiting
NCT05520099 2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
NCT07544680 2026-04-22
ENVISION
Exact Sciences Corporation
Recruiting
NCT06973161 2026-04-08
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
Completed
NCT07041606 2026-02-24
IREN
AstraZeneca
Recruiting
NCT05129969 2026-01-28
SMARAGD
iOMEDICO AG
Recruiting
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT07327489 2026-01-08
ELEPHAS-05
Elephas
Recruiting
NCT06925113 2025-11-17
HERGYN
Daiichi Sankyo
Completed
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT07148154 2025-08-29
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
MiMARK Diagnostics, S.L.
Recruiting
NCT06192017 2025-08-28
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
MiMARK Diagnostics, S.L.
Completed
NCT05059444 2025-08-22
ORACLE
Guardant Health, Inc.
Recruiting
NCT05124743 2025-07-30
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Terminated
NCT05891197 2025-07-01
START
Lyell Immunopharma, Inc.
Terminated
NCT06990971 2025-05-25
CYCLE_ENDO
Cycle Therapeutics Ltd
Not yet recruiting
NCT06024109 2025-05-13
BARHYSTER
Aesculap AG
Recruiting
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT06440018 2025-02-21
INSPIRE
Singlera Genomics Inc.
Recruiting
NCT05375136 2024-03-25
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
Eisai Inc.
Completed
NCT06294886 2024-03-07
Vaginal Fluid Collection for Detection of Endometrial Cancer
Innovis LLC
Unknown
NCT05998798 2023-08-21
Revealing Engagement Patterns Among Endometrial Cancer Patients
Power Life Sciences Inc.
Not yet recruiting
NCT05287048 2023-02-01
Evaluation of MCM5 in Postmenopausal Bleeding Patients
Arquer Diagnostics Ltd
Unknown
NCT05230186 2022-02-09
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
Unknown
NCT02178462 2018-01-31
Biomarkers for Gynecologic Cancer
Ajinomoto Co., Inc.
Unknown
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT00669422 2012-10-05
ChemoFx® PRO - A Post-Market Data Collection Study
Precision Therapeutics
Terminated
NCT01049126 2011-03-16
Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients
Precision Therapeutics
Completed